RS59079B1 - Dermalni injekcioni sterilni sastav - Google Patents

Dermalni injekcioni sterilni sastav

Info

Publication number
RS59079B1
RS59079B1 RS20190862A RSP20190862A RS59079B1 RS 59079 B1 RS59079 B1 RS 59079B1 RS 20190862 A RS20190862 A RS 20190862A RS P20190862 A RSP20190862 A RS P20190862A RS 59079 B1 RS59079 B1 RS 59079B1
Authority
RS
Serbia
Prior art keywords
injectable sterile
sterile composition
dermal
dermal injectable
composition
Prior art date
Application number
RS20190862A
Other languages
English (en)
Inventor
François Bourdon
Stéphane Meunier
Original Assignee
Teoxane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47754646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS59079(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teoxane filed Critical Teoxane
Publication of RS59079B1 publication Critical patent/RS59079B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RS20190862A 2012-10-24 2013-10-24 Dermalni injekcioni sterilni sastav RS59079B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1260146A FR2997014B1 (fr) 2012-10-24 2012-10-24 Composition sterile dermo-injectable
PCT/IB2013/059607 WO2014064632A1 (en) 2012-10-24 2013-10-24 Dermal injectable sterile composition
EP13820892.1A EP2912074B2 (en) 2012-10-24 2013-10-24 Dermal injectable sterile composition

Publications (1)

Publication Number Publication Date
RS59079B1 true RS59079B1 (sr) 2019-09-30

Family

ID=47754646

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20190862A RS59079B1 (sr) 2012-10-24 2013-10-24 Dermalni injekcioni sterilni sastav

Country Status (19)

Country Link
US (2) US9907739B2 (sr)
EP (1) EP2912074B2 (sr)
JP (1) JP6521862B2 (sr)
KR (1) KR102178252B1 (sr)
AU (1) AU2013336274B2 (sr)
BR (1) BR112015009162B1 (sr)
CA (1) CA2888616C (sr)
DK (1) DK2912074T4 (sr)
ES (1) ES2735017T5 (sr)
FR (1) FR2997014B1 (sr)
HR (1) HRP20191196T1 (sr)
HU (1) HUE044362T2 (sr)
PL (1) PL2912074T5 (sr)
PT (1) PT2912074T (sr)
RS (1) RS59079B1 (sr)
RU (1) RU2653729C2 (sr)
SI (1) SI2912074T1 (sr)
TR (1) TR201911149T4 (sr)
WO (1) WO2014064632A1 (sr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6906885B2 (ja) 2014-11-14 2021-07-21 ロレアル しわを減少させるためのマイクロニードルシート
FR3034195B1 (fr) * 2015-03-24 2017-04-21 Teoxane Procede d'evaluation des performances mecaniques d'un gel de comblement
AU2016426150B2 (en) * 2016-10-13 2022-06-30 Allergan, Inc. Coacervate hyaluronan hydrogels for dermal filler applications
WO2018122342A1 (en) * 2016-12-29 2018-07-05 Nestlé Skin Health Sa Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
EP3562470A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
WO2018122343A1 (en) * 2016-12-29 2018-07-05 Nestlé Skin Health Sa Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
CN111727033A (zh) * 2018-02-16 2020-09-29 东洋纺株式会社 防污染剂及皮肤外用组合物
MA52880A (fr) 2018-06-15 2021-09-22 Croma Pharma Ges M B H Composition d'hydrogel comprenant un polymère réticulé
EP3813767A1 (en) 2018-06-29 2021-05-05 The Procter & Gamble Company Dual phase products
WO2020005788A2 (en) 2018-06-29 2020-01-02 The Procter & Gamble Company Dual phase products
JP2021528443A (ja) 2018-06-29 2021-10-21 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 二相製品
TWI708607B (zh) * 2018-07-06 2020-11-01 南韓商Lg化學股份有限公司 同時具有高度黏彈性和內聚性之玻尿酸填料
ES2974233T3 (es) * 2018-07-10 2024-06-26 Lg Chemical Ltd Relleno de ácido hialurónico con alta capacidad de elevación y baja fuerza de inyección
KR102566287B1 (ko) * 2018-11-30 2023-08-11 주식회사 엘지화학 히알루론산을 포함하는 활액보충재용 조성물
BR112021012042A2 (pt) * 2018-12-20 2021-09-21 Lg Chem, Ltd. Preenchedor com excelentes propriedades de preenchedor compreendendo hidrogel de ácido hialurônico
JP1665824S (sr) 2019-08-21 2020-08-11
CN114727941A (zh) * 2019-08-30 2022-07-08 宝洁公司 包装的毛发护理组合物
JP2023545277A (ja) 2020-10-27 2023-10-27 ザ プロクター アンド ギャンブル カンパニー 加温コンディショナー
USD1006632S1 (en) 2020-12-11 2023-12-05 The Procter & Gamble Company Container for hair care products
USD1012718S1 (en) 2020-12-21 2024-01-30 The Procter & Gamble Company Container for hair care product
WO2022217069A1 (en) * 2021-04-09 2022-10-13 Colorado School Of Mines Radical crosslinked zwitterionic gels and uses thereof
CN113896915B (zh) * 2021-11-10 2024-02-13 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法与应用
WO2023082084A1 (zh) 2021-11-10 2023-05-19 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法与应用
KR20240109279A (ko) 2021-11-29 2024-07-10 아이메이커 테크놀러지 디벨롭먼트 캄파니 리미티드 복합 겔, 제조 방법 및 응용
CN118742576A (zh) 2022-01-11 2024-10-01 维库有限公司 作为创新填充剂的新透明质酸衍生物
WO2023221082A1 (zh) * 2022-05-20 2023-11-23 爱美客技术发展股份有限公司 一种接枝聚合物材料及其制备方法与应用
WO2024040480A1 (zh) * 2022-08-24 2024-02-29 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US20040162235A1 (en) * 2003-02-18 2004-08-19 Trubetskoy Vladimir S. Delivery of siRNA to cells using polyampholytes
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
NO20044818D0 (no) 2004-11-05 2004-11-05 Bioforsk As Spermin i kosmetiske preparater
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
ES2636998T3 (es) 2004-11-24 2017-10-10 Albumedix A/S Método de reticulación de ácido hialurónico con divinil sulfona
EP1884231A1 (en) * 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
FR2908415B1 (fr) 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
EP2366386A4 (en) 2008-10-28 2013-11-27 Univ Santiago Compostela NANOPARTICULAR SYSTEMS MADE OF ANIONIC POLYMERS
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
ES2368307B1 (es) * 2010-04-28 2012-10-17 Universidade De Santiago De Compostela Hidrogeles elaborados a base de polímeros aniónicos de origen natural.
WO2012008722A2 (ko) 2010-07-12 2012-01-19 신풍제약 주식회사 조직 증강용 충전 조성물

Also Published As

Publication number Publication date
DK2912074T3 (da) 2019-07-22
SI2912074T1 (sl) 2019-08-30
ES2735017T5 (es) 2022-04-28
US9907739B2 (en) 2018-03-06
US10307362B2 (en) 2019-06-04
HUE044362T2 (hu) 2019-10-28
CA2888616A1 (en) 2014-05-01
WO2014064632A1 (en) 2014-05-01
RU2653729C2 (ru) 2018-05-14
EP2912074A1 (en) 2015-09-02
HRP20191196T1 (hr) 2019-10-18
PL2912074T3 (pl) 2019-09-30
BR112015009162B1 (pt) 2021-10-13
EP2912074B2 (en) 2021-12-22
ES2735017T3 (es) 2019-12-13
US20180140530A1 (en) 2018-05-24
FR2997014B1 (fr) 2015-03-20
KR102178252B1 (ko) 2020-11-13
JP6521862B2 (ja) 2019-05-29
KR20150079786A (ko) 2015-07-08
JP2016507592A (ja) 2016-03-10
TR201911149T4 (tr) 2019-08-21
BR112015009162A2 (pt) 2017-10-03
RU2015118969A (ru) 2016-12-20
EP2912074B1 (en) 2019-05-01
AU2013336274A1 (en) 2015-05-07
PT2912074T (pt) 2019-07-19
PL2912074T5 (pl) 2022-04-04
FR2997014A1 (fr) 2014-04-25
DK2912074T4 (da) 2022-03-14
US20150272851A1 (en) 2015-10-01
AU2013336274B2 (en) 2017-08-24
CA2888616C (en) 2020-09-15

Similar Documents

Publication Publication Date Title
HRP20190300T1 (hr) Štrcaljka
PL2912074T5 (pl) Sterylna kompozycja do wstrzykiwania przez skórę
HK1257028A1 (zh) 可注射製劑
HK1202816A1 (en) Syringe
GB201210082D0 (en) Improved syringe
EP2832391A4 (en) SYRINGE
HRP20190841T1 (hr) Injektabilna formulacija
GB201220354D0 (en) Dermal compositions
GB2500092B (en) Syringe
HK1204551A1 (en) Injectable compositions
HK1251496A1 (zh) 注射器
EP2913076A4 (en) SYRINGE
HK1204947A1 (en) Sterilized composition
EP2887953A4 (en) IMPROVED INJECTABLE FORMULATION OF DAPTOMYCIN
EP2885023A4 (en) SYRINGE